title: Fetal growth and subsequent maternal risk of thyroid cancer.
abstract: Thyroid cancer has peak incidence among women of reproductive age, and growth factors, which have procarcinogenic properties, may play an important etiologic role. However, the association between fetal growth rate during a woman's pregnancy and her subsequent risk of thyroid cancer has not been previously examined. We conducted a national cohort study of 1,837,634 mothers who had a total of 3,588,497 live-births in Sweden in 1973-2008, followed up for thyroid cancer incidence through 2009. There were 2,202 mothers subsequently diagnosed with thyroid cancer in 36.8 million person-years of follow-up. After adjusting for maternal age, height, weight, smoking, and sociodemographic factors, high fetal growth (birth weight standardized for gestational age and sex) was associated with a subsequent increased risk of thyroid cancer in the mother (incidence rate ratio [IRR] per additional 1 standard deviation, 1.05; 95% CI, 1.01-1.09; p = 0.02). Each 1,000 g increase in the infant's birth weight was associated with a 13% increase in the mother's subsequent risk of thyroid cancer (IRR, 1.13; 95% CI, 1.05-1.22; p = 0.001). These findings appeared to involve both papillary and follicular subtypes, and did not vary significantly by the mother's height, weight or smoking status. In this large national cohort study, high fetal growth during a woman's pregnancy was independently associated with a subsequent increased risk of her developing thyroid cancer. If confirmed, these findings suggest an important role of maternal growth factors in the development of thyroid cancer, and potentially may help facilitate the identification of high-risk subgroups of women.
authors.affiliation: Department of Medicine, Stanford University, Stanford, CA.
authors.forename: Casey
authors.initials: C
authors.lastname: Crump
authors.affiliation: Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Malmö, Sweden.
authors.forename: Jan
authors.initials: J
authors.lastname: Sundquist
authors.affiliation: Department of Health Research and Policy, Stanford University, Stanford, CA.
authors.forename: Weiva
authors.initials: W
authors.lastname: Sieh
authors.affiliation: Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, CA.
authors.forename: Marilyn A
authors.initials: MA
authors.lastname: Winkleby
authors.affiliation: Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Malmö, Sweden.
authors.forename: Kristina
authors.initials: K
authors.lastname: Sundquist
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001724:Birth Weight; D015331:Cohort Studies; D005260:Female; D047109:Fetal Development; D006801:Humans; D008875:Middle Aged; D011247:Pregnancy; D012306:Risk; D013964:Thyroid Neoplasms / Q000209:etiology*
keywords: fetal development; mothers; pregnancy; risk factors; thyroid neoplasms